The effect of premedication with morphine and scopolamine, morphine alone, and scnpolamine alone on arterial oxygen tension has been studied in patients with coronary artery disease undergoing bypass operations.
CHANGES IN ARTERIAL OXYGEN TENSION before, during and after anaesthesia are of interest and concern to anaesthetists and surgeons. Many studies have examined the factors responsible for arterial hypoxaemia before, during and after anaesthesia, with conflicting conclusions.
Premedicant drugs may be responsible for changes in oxygenation. However. various reSUitS have been reported with narcotic and vagolytic agents. In some studies, morphine was found to have no effect on Pap2. i.z In others Pao~ decreased following administration of a premedicant dose of morphine. 3'4 Of the vagolytic agents commonly used for premedication, one report indicated a decrease in Pap2 after atropine, s Subsequent studies, however, have been unable to demonstrate an effect of atropine. 6'7 Therefore, we decided to re-evaluate the effects of morphine and scopolamine, morphine alone, and scopolamine alone on arterial oxygen tension in patients with coronary artery disease undergoing bypass operations. Individuals with angina pectoris were selected because a decrease in availability of oxygen is of vital importance for this group of patients. disease were studied. Ages ranged from 36 to 72 years (mean 56). Since a morphine scopolamine premedication is routine practice, patients were informed but no written consents were obtained. Control arterial blood samples were obtained with the patients in the supine position breathing room air the day before operation. A second arterial blood sample was drawn on arrival in the induction room, with the patient breathing room air in the supine position, one hour after premedication. "Fen patients (randomly selected) received only scopolamine (0.4-0.5mg) and ten patients were given morphine (10-15mg) and scopolamine (0.4-0.5mg). Since sublingual nitroglycerine has been shown to reduce Pap2 significantly, g patients receiving sublingual nitroglycerine were excluded from the study. Samples were drawn anaerobically in heparinized syringes and were analyzed in duplicate within five minutes by the same technician on the same instrument (Model 213, Instrumentation Laboratories, Lexington, Massachusetts) to determine cH + (pH), Pap2 and Paeo2. Student's t-test was used for the statistical analysis of the dala.
METHOD AND MATERIAL

RESULTS
Results are summarized in Tables I, It and ill. In lhe first group (scopolamine only), mean Pao~ fell from 10.11 4-1.06to9.58_+ 1.06kPa(76_+ 8to 72 _+ 8 ton) (p < 0.005): cH + (pH) and Paco2 did not change. In the second group (morphine only), cH+(pH), Paoz and Pacn.~ did not change significantly. In the third group, morphine and scopolamine, cH + increased from 38.90 4-3.11 132 
DISCUSSION
This study demonstrates that morphine (10-15mg) and scopolamine (0.4-0.5mg) premedication diminishes Pao2 significantly in patients with coronary artery disease.
In the group receiving scopolamine alone, Pao2 fell by 0.532kPa (4torr). This reduction was statistically significant but of no clinical importance, cH+(pH) and Paco ~ did not change. Since there was no carbon dioxide elevation, reduction in Pao2 was probably due to uneven ventilation produced by the sedative effects of scopolamine. It is our observation that this group was better sedated than the morphine group, but less sedated than the morphine plus scopolamine group. In the group receiving morphine alone, cH+(pH), Paco2 and Pao2 did not change, probably because of persistant anxiety or lack of sedation, which provided a better ventilation-perfusion ratio. Se-dation may not regularly accompany morphine administration. 9 A stable Paco~ after morphine alone and scopolamine alone indicates that neither had produced respiratory dcpression or stimulation.
In the group receiving morphine and scopolamine, cH § increased (pH decreased) and Pao2 fell significantly (p < 0.001). The change in cH+(pH) was statistically significant but of no clinical importance. Although the fall in Pao2 was associated with higher Pacoz values, in some patients the Pao.~ was decreased more than could be accounted for by decreased ventilation, suggesting that other mechanisms were involved. The magnitude of decrease in Pao2 was greater with the combination than with scopolamine alone.
In five of our patients, Pan2 fell to an unacceptable level although the mean value for the group was 7.98kPa (60tort). ST segment change occurred in one of these patients before induction of anaesthesia and returned to normal after several minutes of ventilation with 100 per cent oxygen. Although this suggests that oxygen was helpful, it is also possible that spontaneous resolution of the process could have occurred during the time oxygen was being administered. In patients with coronary artery disease, ST changes may occur any time, even without medications. Thus, it was impossible to determine whether ischaemic change was due to decreased Pao2 or to the disease process.
Reduction of systemic arterial oxygen tension in patients with coronary artery disease or in those with angina pectoris in whom maintenance of adequate oxygen tension is fundamentally important, even transient hypoxaemia may be dangerous. It is possible that morphine and scopolamine-induced arterial hypoxaemia may be one contributing factor in producing preoperative myocardial ischaemia. The present study suggests that when morphine and scopolamine premedication is used on patients with severe coronary artery disease or angina pecloria, simultaneous administration of oxygen is important in helping to eliminate a possible cause of preoperative myocardial ischaemia.
